Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RYTM. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 6,684,248 | $742M | INCREASED |
| RA Capital Management, | 6,666,837 | $740M | UNCHANGED |
| BlackRock | 6,156,902 | $684M | DECREASED |
| Baker Bros. Advisors | 5,604,483 | $622M | UNCHANGED |
| Primecap Management Co | 3,168,853 | $352M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| David P Meeker (President and CEO) | EXERCISE | 50,000 | $303K | 2026-09-14 |
| David P Meeker (President and CEO) | SELL | 2,300 | $242K | 2026-09-14 |
| David P Meeker (President and CEO) | SELL | 1,817 | $190K | 2026-09-14 |
| David P Meeker (President and CEO) | SELL | 8,698 | $900K | 2026-09-14 |
| David P Meeker (President and CEO) | SELL | 30,746 | $3M | 2026-09-14 |
Full institutional holdings, insider history, and congressional trades for Rhythm Pharmaceuticals, Inc. Common Stock on SentiSense.